Fort Point Capital Partners LLC Bio N Tech Se Transaction History

Fort Point Capital Partners LLC

  • $874 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$126.25 - $231.85 $126,250 - $231,850
-1,000 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$205.93 - $447.23 $10,296 - $22,361
-50 Reduced 4.76%
1,000 $273,000
Q2 2021

Jul 30, 2021
BUY
$113.32 - $241.49 $118,986 - $253,564
1,050 New
1,050 $235,000

Others Institutions Holding BNTX

# of Institutions
363
Shares Held
39.6M
Call Options Held
3.01M
Put Options Held
2.01M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.1B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email